Trial of Pemetrexed or Pemetrexed With Gemcitabine for Patients With Advanced Lung Cancer Who Are Not Eligible for Platinum-Based Chemotherapy and Have Not Previously Been Treated With Chemotherapy
Clinical trial NCT00489983 · COMPLETED
Trial details
- NCT number
- NCT00489983
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2003-07-01
- Enrollment
- 91
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.